Applied BioCode Market Cap ($91.98 Million)
Market Cap & Net Worth: Applied BioCode (6598)
Applied BioCode market cap. Applied BioCode (TW:6598) has a market capitalization of $91.98 Million (NT$2.92 Billion) as of November 1, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #19333 globally and #1111 in its home market, demonstrating a -6.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Applied BioCode's stock price NT$28.40 by its total outstanding shares 102801000 (102.80 Million). Also see 6598 cash flow conversion for how efficiently the company converts equity into cash flow.
Applied BioCode Market Cap History (2017–2026)
Applied BioCode market cap history from 2017 to 2026. Data shows change from $124.66 Million to $91.98 Million (-8.57% CAGR). Check Applied BioCode (6598) share price today for real-time trading data and today's change.
Applied BioCode Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Applied BioCode's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Applied BioCode to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.19x
Applied BioCode's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $124.66 Million | $26.76 Million | -$263.46 Million | 4.66x | N/A |
| 2018 | $125.44 Million | $37.15 Million | -$268.31 Million | 3.38x | N/A |
| 2019 | $124.05 Million | $104.69 Million | -$280.07 Million | 1.18x | N/A |
| 2020 | $190.44 Million | $299.01 Million | -$103.50 Million | 0.64x | N/A |
| 2021 | $139.27 Million | $319.96 Million | -$165.20 Million | 0.44x | N/A |
| 2022 | $100.40 Million | $390.30 Million | -$184.73 Million | 0.26x | N/A |
| 2023 | $81.94 Million | $395.17 Million | -$164.20 Million | 0.21x | N/A |
| 2024 | $65.26 Million | $343.07 Million | -$260.81 Million | 0.19x | N/A |
Competitor Companies of 6598 by Market Capitalization
Companies near Applied BioCode in the global market cap rankings as of November 1, 2026. Also see Applied BioCode assets under control for a full breakdown of the balance sheet.
Key companies related to Applied BioCode by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Applied BioCode (2017–2026)
Market capitalization of Applied BioCode from 2017 to today. Between 2017 and today, Applied BioCode's market cap moved from $124.66 Million to $ 91.98 Million, with a yearly change of -8.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$91.98 Million | +29.09% |
| 2025 | NT$71.25 Million | +9.18% |
| 2024 | NT$65.26 Million | -20.36% |
| 2023 | NT$81.94 Million | -18.39% |
| 2022 | NT$100.40 Million | -27.91% |
| 2021 | NT$139.27 Million | -26.87% |
| 2020 | NT$190.44 Million | +53.52% |
| 2019 | NT$124.05 Million | -1.11% |
| 2018 | NT$125.44 Million | +0.63% |
| 2017 | NT$124.66 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Applied BioCode was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $91.98 Million USD |
| MoneyControl | $91.98 Million USD |
| MarketWatch | $91.98 Million USD |
| marketcap.company | $91.98 Million USD |
| Reuters | $91.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Applied BioCode
Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. Its products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the detection steps, PCR amplification, and hybridization and target capture; and the BioCode 2500 analyzer, a system that reads each barcode and quantifies the BMB target us… Read more